E.g., 25-10-2021
E.g., 25-10-2021
We have found 103 results.
View by: Grid List
Sort by: Relevancy Date
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    A Crabwise ‘Recoupling’

    The Biden administration continues its crabwise efforts to craft a China strategy balancing national security and economic interests. The challenge is that Biden wants to maintain the basic stance established by Donald Trump—“strategic competition”—while satisfying a wider range of interest groups and setting more realistic policy targets.

    5
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Vaccine Slippage

    It is looking likely that most countries will miss their Covid-19 vaccination targets for 2021. This creates a risk of slower than expected economic growth, especially in Europe which take half a year to emerge from its double-dip recession. Moreover, any activity dependent on international travel or large-scale gatherings will remain severely depressed until well into 2022.

    3
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Edging Toward A New Cold War

    The US decision to close China’s consulate in Houston is a big deal. The precise motivations are obscure but the story is not: the Trump Administration is turning up the heat on China before the US presidential election. In the next few months Washington is likely to make new moves pushing the US closer to a Cold War posture against China.

    1
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Rising US Covid Risk

    In the coming weeks, the headlines about Covid-19 in the US are all but certain to get much worse as case numbers rocket in many southern and western states. Higher case numbers will be accompanied by more hospitalizations, stories of overloaded hospital systems and (probably) rising death tolls.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    A US Full-Court Press Against China

    The US-China relationship has deteriorated rapidly, and the main reason seems to be that Donald Trump has decided that a “tough on China” approach should be central to his reelection campaign. Acrimony between the two countries is likely to get much worse between now and November, and US actions are starting to spread from technology to finance.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Heading In The Right Direction, Slowly

    The Covid-19 epidemic now seems firmly under control in most major economies, and the direction of the disease data is consistently positive. From an infection-control perspective, the outlook is much more positive than when we did our last major review. The path to economic recovery, however, still looks slow and rocky.

    3
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Lockdowns Loom; What’s The Exit Strategy?

    We are heading into another difficult week. Covid-19 case numbers and fatalities outside China continue to grow rapidly. Social lockdowns are spreading to more US states and European countries. In the short run, fiscal support is on the way. Longer term, governments will have to start asking the uncomfortable question of when the economic pain outweighs the public health gain.

    1
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Six Degrees Of Uncertainty

    World markets are in full-on panic mode, thanks to a cloud of unknowing that has settled over two topics of broad importance: the spread and economic impact of the coronavirus, and the outcome of the oil-price war between Saudi Arabia and Russia. The topics are related, and so we are grappling with the problem of pricing epidemic-related uncertainty.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    A Tough Ask On Trade, Trouble Brewing On Tech

    The story we’ve been telling for the past few months is that the conclusion of the US-China trade deal will reduce global macro risk in 2020, but tech-specific risk will still be an issue because of continued efforts by the US to constrain the rise of China’s technology sector and in particular Huawei. This week’s news buttressed that story: the trade deal was signed; but at the same time several US agencies are on the verge of tightening...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Trade War’s Uneasy Truce

    The “phase one” US-China trade deal announced last week still has some hoops to pass through before it becomes real: completion of a bilingual legal text and formal signing in January. Still, both sides have incentives to avoid the economic damage from further tariff escalation, so the deal will almost surely come into force. The agreement falls far short of achieving the US goal of forcing China to change its state-led economic system; instead...

    3
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    China-Bashing In A Political Season

    Signs are growing that the US and China will have a mini-deal on trade ready by the time Trump and Xi meet at the mid-November APEC summit. The key questions are whether opposition from US hardliners could derail the deal at the last moment, and whether the campaign to “decouple” the two economies will be knocked back if there is a deal.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Trump’s Unreal Deal With China

    The US-China trade cease-fire shows that President Trump needs a quick deal: facing a soft economy and likely impeachment, he wants to bank a win as soon as possible. The two sides are moving toward a deal in November, but that will not change China's economic model or end US efforts to constrain China's technological rise.

    1
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    A Trade Equilibrium Of Sorts

    After a week of trade war scares, things have settled down into an equilibrium that is uneasy, but likely to last several weeks. The central question now is whether the new tariff on US$300bn of Chinese exports to the US will go into effect on September 1, or if Trump’s team will find some graceful way to back down from that threat.

    2
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Renminbi, Manipulation And The Trade War

    Monday’s actions on the Chinese currency—Beijing’s decision to let the renminbi’s exchange rate weaken past CNY7.00 to the US dollar, and Washington’s decision to label China a currency manipulator—signal that the US and China are close to throwing in the towel on a trade deal. Trade war escalation should now be the base case.

    1
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Shanghai Talks Now A Sideshow

    Trade talks between the US and China resume today after a three-month hiatus. This meeting may or may not pave the way for a deal in the next several months, but it no longer matters much. The global macro risk from the trade conflict has ebbed dramatically. What's important now is the dimensions of the decoupling between the world’s two biggest economies.

    1
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    A Cold War Interglacial

    It is now almost certain that presidents Donald Trump and Xi Jinping will restart trade talks at the G20 summit in Osaka this weekend. Moreover, discussions in Washington suggest that there is a good chance these talks will result in a deal in the next few months. Our core scenario now is that macro risk from an escalating trade war is receding. There are also signs that the US and China could negotiate a truce on Huawei, lifting the apparent...

    7
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Keeping China In Play

    Next week’s big event will be the G-20 leaders’ meeting in Osaka, where presidents Donald Trump and Xi Jinping will sit down to figure out whether their stalled trade negotiations can be re-started. It is quite likely that trade talks will get back on track, but quite unlikely that a deal can actually be struck before the end of the year.

    2
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Trump's Trade War Calculus

    Keeping track of all the pieces of the US-China confrontation has become a full-time job. But the chaos and uncertainty of the past couple of weeks has begun to resolve itself into fairly clear patterns, even if the outcomes remain in doubt. Three main conclusions emerge from last week’s activity, and none of them are particularly reassuring.

    10
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Trade War Story Lines Harden

    The US-China trade war has three potential outcomes. First, we could see a step back from brinksmanship and a deal in the next few weeks. Second, the two sides could dig in for more protracted negotiations. Third, the talks could break down and the trade war become permanent. With the probability of each outcome less than 50%, the only certainty is continued uncertainty.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Trade Deal Delayed, Not Yet Denied

    Any trade negotiator will tell you that the last yard is always the hardest. That is obvious now in the US-China trade talks, which were thrown into doubt by Donald Trump’s weekend tweets threatening to hike tariffs on US$200bn of imports from China from 10% to 25% this Friday if a deal is not done.

    2
Show me: results